Parainfluenza 3 BY PCR

Parainfluenza 3 BY PCR is a molecular diagnostic test that detects the genetic material (RNA) of human parainfluenza virus type 3 (PIV‑3) in respiratory specimens using real‑time reverse transcription PCR (RT‑PCR). The assay identifies active infection with high sensitivity and specificity, helping distinguish PIV‑3 from other respiratory pathogens. It is particularly important for infants, young children, older adults and immunocompromised patients where PIV‑3 can cause bronchiolitis or pneumonia.

This at‑home service includes professional sample collection across Dubai, secure transport to an accredited laboratory, and fast result reporting to support timely clinical decisions and infection control. The test is useful for symptomatic individuals, outbreak investigations in schools or care facilities, and for clinicians who need to rule in or out PIV‑3 as the cause of acute respiratory illness; always review results with a healthcare professional for management and follow‑up.

• Parainfluenza 3 (PIV‑3) RNA — Qualitative
• Cycle threshold (Ct) value — reported when applicable
• Specimen type — Nasopharyngeal / Oropharyngeal swab
• Test method — Real‑time RT‑PCR

• Acute onset of cough, wheeze or difficulty breathing
• Infants or young children with bronchiolitis or persistent fever
• Older adults or immunocompromised patients with respiratory symptoms
• Suspected respiratory outbreak in schools, nurseries or care homes
• When differentiation from influenza, RSV or COVID‑19 is needed

• High sensitivity RT‑PCR for accurate detection of active PIV‑3 infection
• Professional at‑home sample collection across Dubai to minimize exposure
• Fast laboratory turnaround to support timely clinical decisions
• Convenient reporting and clinician guidance for result interpretation
• Reduced need for travel to hospitals or clinics, lowering transmission risk

• At‑home nasopharyngeal or combined naso‑/oropharyngeal swab collected by a trained professional
• No fasting required; avoid nasal sprays or vigorous nose blowing 30 minutes before collection
• Optimal sample collection within 5–7 days of symptom onset for best sensitivity
• Valid Emirates ID, full Dubai address for home visit booking and payment in AED